ID   POLG_POL1M              Reviewed;        2209 AA.
AC   P03300; P03299; Q84879; Q84880; Q89679;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   24-JUN-2015, entry version 176.
DE   RecName: Full=Genome polyprotein;
DE   Contains:
DE     RecName: Full=P1;
DE   Contains:
DE     RecName: Full=Capsid protein VP0;
DE     AltName: Full=VP4-VP2;
DE   Contains:
DE     RecName: Full=Capsid protein VP4;
DE     AltName: Full=P1A;
DE     AltName: Full=Virion protein 4;
DE   Contains:
DE     RecName: Full=Capsid protein VP2;
DE     AltName: Full=P1B;
DE     AltName: Full=Virion protein 2;
DE   Contains:
DE     RecName: Full=Capsid protein VP3;
DE     AltName: Full=P1C;
DE     AltName: Full=Virion protein 3;
DE   Contains:
DE     RecName: Full=Capsid protein VP1;
DE     AltName: Full=P1D;
DE     AltName: Full=Virion protein 1;
DE   Contains:
DE     RecName: Full=P2;
DE   Contains:
DE     RecName: Full=Protease 2A;
DE              Short=P2A;
DE              EC=3.4.22.29;
DE     AltName: Full=Picornain 2A;
DE     AltName: Full=Protein 2A;
DE   Contains:
DE     RecName: Full=Protein 2B;
DE              Short=P2B;
DE   Contains:
DE     RecName: Full=Protein 2C;
DE              Short=P2C;
DE              EC=3.6.1.15;
DE   Contains:
DE     RecName: Full=P3;
DE   Contains:
DE     RecName: Full=Protein 3AB;
DE   Contains:
DE     RecName: Full=Protein 3A;
DE              Short=P3A;
DE   Contains:
DE     RecName: Full=Viral protein genome-linked;
DE              Short=VPg;
DE     AltName: Full=Protein 3B;
DE              Short=P3B;
DE   Contains:
DE     RecName: Full=Protein 3CD;
DE              EC=3.4.22.28;
DE   Contains:
DE     RecName: Full=Protease 3C;
DE              Short=P3C;
DE              EC=3.4.22.28;
DE   Contains:
DE     RecName: Full=RNA-directed RNA polymerase;
DE              Short=RdRp;
DE              EC=2.7.7.48;
DE     AltName: Full=3D polymerase;
DE              Short=3Dpol;
DE     AltName: Full=Protein 3D;
DE              Short=3D;
OS   Poliovirus type 1 (strain Mahoney).
OC   Viruses; ssRNA viruses; ssRNA positive-strand viruses, no DNA stage;
OC   Picornavirales; Picornaviridae; Enterovirus; Enterovirus C.
OX   NCBI_TaxID=12081;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=6264310; DOI=10.1038/291547a0;
RA   Kitamura N., Semler B.L., Rothberg P.G., Larsen G.R., Adler C.J.,
RA   Dorner A.J., Emini E.A., Hanecak R., Lee J.J., van der Werf S.,
RA   Anderson C.W., Wimmer E.;
RT   "Primary structure, gene organization and polypeptide expression of
RT   poliovirus RNA.";
RL   Nature 291:547-553(1981).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=6272282; DOI=10.1073/pnas.78.8.4887;
RA   Racaniello V.R., Baltimore D.;
RT   "Molecular cloning of poliovirus cDNA and determination of the
RT   complete nucleotide sequence of the viral genome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 78:4887-4891(1981).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-69.
RX   PubMed=6284987;
RA   Dorner A.J., Dorner L.F., Larsen G.R., Wimmer E., Anderson C.W.;
RT   "Identification of the initiation site of poliovirus polyprotein
RT   synthesis.";
RL   J. Virol. 42:1017-1028(1982).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA] OF 1539-1574, AND FUNCTION (VIRAL
RP   PROTEIN GENOME-LINKED).
RX   PubMed=6250717; DOI=10.1016/0092-8674(80)90137-3;
RA   Kitamura N., Adler C.J., Rothberg P.G., Martinko J., Nathenson S.G.,
RA   Wimmer E.;
RT   "The genome-linked protein of picornaviruses. VII. Genetic mapping of
RT   poliovirus VPg by protein and RNA sequence studies.";
RL   Cell 21:295-302(1980).
RN   [5]
RP   FUNCTION (VIRAL PROTEIN GENOME-LINKED), AND COVALENT RNA-LINKAGE AT
RP   TYR-1546 PF VPG.
RX   PubMed=209034;
RA   Ambros V., Baltimore D.;
RT   "Protein is linked to the 5' end of poliovirus RNA by a phosphodiester
RT   linkage to tyrosine.";
RL   J. Biol. Chem. 253:5263-5266(1978).
RN   [6]
RP   ACTIVE SITE (RNA-DIRECTED RNA POLYMERASE).
RX   PubMed=2196557; DOI=10.1093/protein/3.6.461;
RA   Delarue M., Poch O., Tordo N., Moras D., Argos P.;
RT   "An attempt to unify the structure of polymerases.";
RL   Protein Eng. 3:461-467(1990).
RN   [7]
RP   MYRISTOYLATION AT GLY-2, AND MUTAGENESIS OF ALA-3.
RX   PubMed=1850017;
RA   Moscufo N., Simons J., Chow M.;
RT   "Myristoylation is important at multiple stages in poliovirus
RT   assembly.";
RL   J. Virol. 65:2372-2380(1991).
RN   [8]
RP   MYRISTOYLATION AT GLY-2, AND MUTAGENESIS OF GLY-2.
RX   PubMed=1851815;
RA   Marc D., Girard M., van der Werf S.;
RT   "A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks
RT   its myristoylation and prevents viral assembly.";
RL   J. Gen. Virol. 72:1151-1157(1991).
RN   [9]
RP   FUNCTION (PROTEIN 2C).
RX   PubMed=8385138;
RA   Rodriguez P.L., Carrasco L.;
RT   "Poliovirus protein 2C has ATPase and GTPase activities.";
RL   J. Biol. Chem. 268:8105-8110(1993).
RN   [10]
RP   INTERACTION OF PROTEIN 3AB WITH PROTEIN 3CD.
RX   PubMed=7929441;
RA   Harris K.S., Xiang W., Alexander L., Lane W.S., Paul A.V., Wimmer E.;
RT   "Interaction of poliovirus polypeptide 3CDpro with the 5' and 3'
RT   termini of the poliovirus genome. Identification of viral and cellular
RT   cofactors needed for efficient binding.";
RL   J. Biol. Chem. 269:27004-27014(1994).
RN   [11]
RP   FUNCTION (PROTEASE 2A).
RX   PubMed=9755863; DOI=10.1016/S0014-5793(98)01027-8;
RA   Ventoso I., MacMillan S.E., Hershey J.W., Carrasco L.;
RT   "Poliovirus 2A proteinase cleaves directly the eIF-4G subunit of eIF-
RT   4F complex.";
RL   FEBS Lett. 435:79-83(1998).
RN   [12]
RP   FUNCTION (PROTEIN 3B), COVALENT RNA-LINKAGE AT TYR-1546 OF VPG, AND
RP   URIDYLYLATION AT TYR-1546.
RX   PubMed=12502805; DOI=10.1128/JVI.77.2.891-904.2003;
RA   Paul A.V., Peters J., Mugavero J., Yin J., van Boom J.H., Wimmer E.;
RT   "Biochemical and genetic studies of the VPg uridylylation reaction
RT   catalyzed by the RNA polymerase of poliovirus.";
RL   J. Virol. 77:891-904(2003).
RN   [13]
RP   HOMODIMERIZATION (PROTEIN 3A).
RX   PubMed=12823963; DOI=10.1016/S0022-2836(03)00577-1;
RA   Strauss D.M., Glustrom L.W., Wuttke D.S.;
RT   "Towards an understanding of the poliovirus replication complex: the
RT   solution structure of the soluble domain of the poliovirus 3A
RT   protein.";
RL   J. Mol. Biol. 330:225-234(2003).
RN   [14]
RP   SUBUNIT (PROTEIN 3A), AND CAUTION.
RX   PubMed=16138011;
RA   Kondratova A.A., Neznanov N., Kondratov R.V., Gudkov A.V.;
RT   "Poliovirus protein 3A binds and inactivates LIS1, causing block of
RT   membrane protein trafficking and deregulation of cell division.";
RL   Cell Cycle 4:1403-1410(2005).
RN   [15]
RP   FUNCTION (PROTEIN 3A).
RX   PubMed=15914217; DOI=10.1016/j.virol.2005.03.036;
RA   Choe S.S., Dodd D.A., Kirkegaard K.;
RT   "Inhibition of cellular protein secretion by picornaviral 3A
RT   proteins.";
RL   Virology 337:18-29(2005).
RN   [16]
RP   FUNCTION (VIRAL PROTEIN GENOME-LINKED), COVALENT RNA-LINKAGE AT
RP   TYR-1546 OF VPG, AND URIDYLYLATION AT TYR-1546.
RX   PubMed=16840321; DOI=10.1128/JVI.02533-05;
RA   Richards O.C., Spagnolo J.F., Lyle J.M., Vleck S.E., Kuchta R.D.,
RA   Kirkegaard K.;
RT   "Intramolecular and intermolecular uridylylation by poliovirus RNA-
RT   dependent RNA polymerase.";
RL   J. Virol. 80:7405-7415(2006).
RN   [17]
RP   INTERACTION OF PROTEIN 3A WITH HOST GBF1.
RX   PubMed=17005635; DOI=10.1128/JVI.01225-06;
RA   Wessels E., Duijsings D., Lanke K.H., van Dooren S.H., Jackson C.L.,
RA   Melchers W.J., van Kuppeveld F.J.;
RT   "Effects of picornavirus 3A Proteins on Protein Transport and GBF1-
RT   dependent COP-I recruitment.";
RL   J. Virol. 80:11852-11860(2006).
RN   [18]
RP   INTERACTION OF PROTEIN 2C WITH HUMAN RTN3.
RX   PubMed=17182608; DOI=10.1074/jbc.M611145200;
RA   Tang W.-F., Yang S.-Y., Wu B.-W., Jheng J.-R., Chen Y.-L., Shih C.-H.,
RA   Lin K.-H., Lai H.-C., Tang P., Horng J.-T.;
RT   "Reticulon 3 binds the 2C protein of enterovirus 71 and is required
RT   for viral replication.";
RL   J. Biol. Chem. 282:5888-5898(2007).
RN   [19]
RP   FUNCTION (PROTEIN 3A).
RX   PubMed=17079330; DOI=10.1128/JVI.01820-06;
RA   Belov G.A., Altan-Bonnet N., Kovtunovych G., Jackson C.L.,
RA   Lippincott-Schwartz J., Ehrenfeld E.;
RT   "Hijacking components of the cellular secretory pathway for
RT   replication of poliovirus RNA.";
RL   J. Virol. 81:558-567(2007).
RN   [20]
RP   FUNCTION (CAPSID PROTEIN VP1), FUNCTION (CAPSID PROTEIN VP2), AND
RP   FUNCTION (CAPSID PROTEIN VP3).
RX   PubMed=17622193; DOI=10.1371/journal.pbio.0050183;
RA   Brandenburg B., Lee L.Y., Lakadamyali M., Rust M.J., Zhuang X.,
RA   Hogle J.M.;
RT   "Imaging poliovirus entry in live cells.";
RL   PLoS Biol. 5:E183-E183(2007).
RN   [21]
RP   FUNCTION (CAPSID PROTEIN VP1), FUNCTION (CAPSID PROTEIN VP2), AND
RP   FUNCTION (CAPSID PROTEIN VP3).
RC   STRAIN=Sabin 2;
RX   PubMed=17717529; DOI=10.1038/sj.emboj.7601831;
RA   Coyne C.B., Kim K.S., Bergelson J.M.;
RT   "Poliovirus entry into human brain microvascular cells requires
RT   receptor-induced activation of SHP-2.";
RL   EMBO J. 26:4016-4028(2007).
RN   [22]
RP   INTERACTION OF PROTEIN 3B WITH PROTEIN 3D.
RX   PubMed=17409142; DOI=10.1128/JVI.02252-06;
RA   Strauss D.M., Wuttke D.S.;
RT   "Characterization of protein-protein interactions critical for
RT   poliovirus replication: analysis of 3AB and VPg binding to the RNA-
RT   dependent RNA polymerase.";
RL   J. Virol. 81:6369-6378(2007).
RN   [23]
RP   TOPOLOGY (PROTEIN 3A AND PROTEIN 3AB).
RX   PubMed=17417822; DOI=10.1021/bi6024758;
RA   Fujita K., Krishnakumar S.S., Franco D., Paul A.V., London E.,
RA   Wimmer E.;
RT   "Membrane topography of the hydrophobic anchor sequence of poliovirus
RT   3A and 3AB proteins and the functional effect of 3A/3AB membrane
RT   association upon RNA replication.";
RL   Biochemistry 46:5185-5199(2007).
RN   [24]
RP   FUNCTION (PROTEASE 3C).
RX   PubMed=18632855; DOI=10.1128/JVI.00006-08;
RA   Bonderoff J.M., Larey J.L., Lloyd R.E.;
RT   "Cleavage of poly(A)-binding protein by poliovirus 3C proteinase
RT   inhibits viral internal ribosome entry site-mediated translation.";
RL   J. Virol. 82:9389-9399(2008).
RN   [25]
RP   FUNCTION (CAPSID PROTEIN VP1), FUNCTION (CAPSID PROTEIN VP2), AND
RP   FUNCTION (CAPSID PROTEIN VP3).
RX   PubMed=18191571; DOI=10.1016/j.tim.2007.12.004;
RA   Bergelson J.M.;
RT   "New (fluorescent) light on poliovirus entry.";
RL   Trends Microbiol. 16:44-47(2008).
RN   [26]
RP   REVIEW (PROTEIN 2B).
RX   PubMed=18216106; DOI=10.1128/JVI.02076-07;
RA   de Jong A.S., de Mattia F., Van Dommelen M.M., Lanke K.,
RA   Melchers W.J., Willems P.H., van Kuppeveld F.J.;
RT   "Functional analysis of picornavirus 2B proteins: effects on calcium
RT   homeostasis and intracellular protein trafficking.";
RL   J. Virol. 82:3782-3790(2008).
RN   [27]
RP   FUNCTION (PROTEASE 3C).
RX   PubMed=17993457; DOI=10.1074/jbc.M707907200;
RA   Shen M., Reitman Z.J., Zhao Y., Moustafa I., Wang Q., Arnold J.J.,
RA   Pathak H.B., Cameron C.E.;
RT   "Picornavirus genome replication. Identification of the surface of the
RT   poliovirus (PV) 3C dimer that interacts with PV 3Dpol during VPg
RT   uridylylation and construction of a structural model for the PV 3C2-
RT   3Dpol complex.";
RL   J. Biol. Chem. 283:875-888(2008).
RN   [28]
RP   FUNCTION (PROTEIN 2A).
RX   PubMed=19789179; DOI=10.1242/jcs.055988;
RA   Castello A., Izquierdo J.M., Welnowska E., Carrasco L.;
RT   "RNA nuclear export is blocked by poliovirus 2A protease and is
RT   concomitant with nucleoporin cleavage.";
RL   J. Cell Sci. 122:3799-3809(2009).
RN   [29]
RP   FUNCTION (PROTEIN 2C).
RX   PubMed=19520852; DOI=10.1074/jbc.M109.031807;
RA   Adams P., Kandiah E., Effantin G., Steven A.C., Ehrenfeld E.;
RT   "Poliovirus 2C protein forms homo-oligomeric structures required for
RT   ATPase activity.";
RL   J. Biol. Chem. 284:22012-22021(2009).
RN   [30]
RP   REVIEW (RNA-DIRECTED RNA POLYMERASE).
RX   PubMed=18487072; DOI=10.1016/j.biocel.2008.03.019;
RA   Kok C.C., McMinn P.C.;
RT   "Picornavirus RNA-dependent RNA polymerase.";
RL   Int. J. Biochem. Cell Biol. 41:498-502(2009).
RN   [31]
RP   INTERACTION OF CAPSID PROTEIN VP3 WITH PROTEIN 2C, AND FUNCTION OF
RP   CAPSID PROTEIN VP3.
RX   PubMed=20865167; DOI=10.1371/journal.ppat.1001066;
RA   Liu Y., Wang C., Mueller S., Paul A.V., Wimmer E., Jiang P.;
RT   "Direct interaction between two viral proteins, the nonstructural
RT   protein 2C and the capsid protein VP3, is required for enterovirus
RT   morphogenesis.";
RL   PLoS Pathog. 6:E1001066-E1001066(2010).
RN   [32]
RP   FUNCTION (VIRAL PROTEIN GENOME-LINKED).
RX   PubMed=20441784; DOI=10.1016/j.peptides.2010.04.021;
RA   Schein C.H., Oezguen N., van der Heden van Noort G.J., Filippov D.V.,
RA   Paul A., Kumar E., Braun W.;
RT   "NMR solution structure of poliovirus uridylyated peptide linked to
RT   the genome (VPgpU).";
RL   Peptides 31:1441-1448(2010).
RN   [33]
RP   FUNCTION (PROTEIN 3AB).
RX   PubMed=21045553; DOI=10.4161/rna.7.6.13781;
RA   Gangaramani D.R., Eden E.L., Shah M., Destefano J.J.;
RT   "The twenty-nine amino acid C-terminal cytoplasmic domain of
RT   poliovirus 3AB is critical for nucleic acid chaperone activity.";
RL   RNA Biol. 7:820-829(2010).
RN   [34]
RP   TOPOLOGY (PROTEIN 2B).
RX   PubMed=21835803; DOI=10.1128/JVI.05421-11;
RA   Martinez-Gil L., Bano-Polo M., Redondo N., Sanchez-Martinez S.,
RA   Nieva J.L., Carrasco L., Mingarro I.;
RT   "Membrane integration of poliovirus 2B viroporin.";
RL   J. Virol. 85:11315-11324(2011).
RN   [35]
RP   SUBUNIT OF PROTEIN 3A AND PROTEIN 3AB.
RX   PubMed=21345960; DOI=10.1128/JVI.02398-10;
RA   Teterina N.L., Pinto Y., Weaver J.D., Jensen K.S., Ehrenfeld E.;
RT   "Analysis of poliovirus protein 3A interactions with viral and
RT   cellular proteins in infected cells.";
RL   J. Virol. 85:4284-4296(2011).
RN   [36]
RP   FUNCTION (PROTEIN 2C).
RX   PubMed=22761387; DOI=10.1128/JVI.00914-12;
RA   Wang C., Jiang P., Sand C., Paul A.V., Wimmer E.;
RT   "Alanine scanning of poliovirus 2CATPase reveals new genetic evidence
RT   that capsid protein/2CATPase interactions are essential for
RT   morphogenesis.";
RL   J. Virol. 86:9964-9975(2012).
RN   [37]
RP   CHARACTERIZATION OF N-TERMINUS (CAPSID PROTEIN VP1).
RX   PubMed=23085162; DOI=10.1016/j.jmgm.2012.06.009;
RA   Roberts J.A., Kuiper M.J., Thorley B.R., Smooker P.M., Hung A.;
RT   "Investigation of a predicted N-terminal amphipathic alpha-helix using
RT   atomistic molecular dynamics simulation of a complete prototype
RT   poliovirus virion.";
RL   J. Mol. Graph. Model. 38:165-173(2012).
RN   [38]
RP   FUNCTION (CAPSID PROTEIN VP1 AND CAPSID PROTEIN VP4).
RX   PubMed=23365424; DOI=10.1128/JVI.03209-12;
RA   Strauss M., Levy H.C., Bostina M., Filman D.J., Hogle J.M.;
RT   "RNA transfer from poliovirus 135S particles across membranes is
RT   mediated by long umbilical connectors.";
RL   J. Virol. 87:3903-3914(2013).
RN   [39]
RP   MULTIMERIZATION (RNA-DIRECTED RNA POLYMERASE).
RX   PubMed=23583774; DOI=10.1016/j.jmb.2013.04.007;
RA   Wang J., Lyle J.M., Bullitt E.;
RT   "Surface for catalysis by poliovirus RNA-dependent RNA polymerase.";
RL   J. Mol. Biol. 425:2529-2540(2013).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 1-881.
RX   PubMed=2994218; DOI=10.1126/science.2994218;
RA   Hogle J.M., Chow M., Filman D.J.;
RT   "Three-dimensional structure of poliovirus at 2.9-A resolution.";
RL   Science 229:1358-1365(1985).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.88 ANGSTROMS) OF 2-880.
RX   PubMed=2548847;
RA   Filman D.J., Syed R., Chow M., Macadam A.J., Minor P.D., Hogle J.M.;
RT   "Structural factors that control conformational transitions and
RT   serotype specificity in type 3 poliovirus.";
RL   EMBO J. 8:1567-1579(1989).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 2-880.
RX   PubMed=7849583; DOI=10.1002/pro.5560031005;
RA   Basavappa R., Syed R., Flore O., Icenogle J.P., Filman D.J.,
RA   Hogle J.M.;
RT   "Role and mechanism of the maturation cleavage of VP0 in poliovirus
RT   assembly: structure of the empty capsid assembly intermediate at 2.9 A
RT   resolution.";
RL   Protein Sci. 3:1651-1669(1994).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 1-881.
RX   PubMed=7820548; DOI=10.1016/S0960-9822(00)00176-7;
RA   Grant R.A., Hiremath C.N., Filman D.J., Syed R., Andries K.,
RA   Hogle J.M.;
RT   "Structures of poliovirus complexes with anti-viral drugs:
RT   implications for viral stability and drug design.";
RL   Curr. Biol. 4:784-797(1994).
RN   [44]
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.0 ANGSTROMS) OF 1-881, AND
RP   MYRISTOYLATION AT GLY-2.
RX   PubMed=10618374; DOI=10.1073/pnas.97.1.79;
RA   He Y., Bowman V.D., Mueller S., Bator C.M., Bella J., Peng X.,
RA   Baker T.S., Wimmer E., Kuhn R.J., Rossmann M.G.;
RT   "Interaction of the poliovirus receptor with poliovirus.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:79-84(2000).
RN   [45]
RP   STRUCTURE BY ELECTRON MICROSCOPY (15.0 ANGSTROMS) OF 2-881.
RX   PubMed=12663789; DOI=10.1128/JVI.77.8.4827-4835.2003;
RA   He Y., Mueller S., Chipman P.R., Bator C.M., Peng X., Bowman V.D.,
RA   Mukhopadhyay S., Wimmer E., Kuhn R.J., Rossmann M.G.;
RT   "Complexes of poliovirus serotypes with their common cellular
RT   receptor, CD155.";
RL   J. Virol. 77:4827-4835(2003).
RN   [46]
RP   STRUCTURE BY ELECTRON MICROSCOPY (11.0 ANGSTROMS) OF 97-880.
RX   PubMed=15919927; DOI=10.1128/JVI.79.12.7745-7755.2005;
RA   Bubeck D., Filman D.J., Cheng N., Steven A.C., Hogle J.M.,
RA   Belnap D.M.;
RT   "The structure of the poliovirus 135S cell entry intermediate at 10-
RT   angstrom resolution reveals the location of an externalized
RT   polypeptide that binds to membranes.";
RL   J. Virol. 79:7745-7755(2005).
RN   [47]
RP   STRUCTURE BY ELECTRON MICROSCOPY (8.0 ANGSTROMS) OF 2-881.
RX   PubMed=19011098; DOI=10.1073/pnas.0807848105;
RA   Zhang P., Mueller S., Morais M.C., Bator C.M., Bowman V.D.,
RA   Hafenstein S., Wimmer E., Rossmann M.G.;
RT   "Crystal structure of CD155 and electron microscopic studies of its
RT   complexes with polioviruses.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:18284-18289(2008).
RN   [48]
RP   STRUCTURE BY ELECTRON MICROSCOPY OF 97-341 AND 647-881.
RX   PubMed=20181687; DOI=10.1128/JVI.02393-09;
RA   Levy H.C., Bostina M., Filman D.J., Hogle J.M.;
RT   "Catching a virus in the act of RNA release: a novel poliovirus
RT   uncoating intermediate characterized by cryo-electron microscopy.";
RL   J. Virol. 84:4426-4441(2010).
CC   -!- FUNCTION: Capsid protein VP1: Forms an icosahedral capsid of
CC       pseudo T=3 symmetry with capsid proteins VP2 and VP3. The capsid
CC       is 300 Angstroms in diameter, composed of 60 copies of each capsid
CC       protein and enclosing the viral positive strand RNA genome. Capsid
CC       protein VP1 mainly forms the vertices of the capsid. Capsid
CC       protein VP1 interacts with host cell receptor PVR to provide
CC       virion attachment to target host epithelial cells. This attachment
CC       induces virion internalization predominantly through clathrin- and
CC       caveolin-independent endocytosis in Hela cells and through
CC       caveolin-mediated endocytosis in brain microvascular endothelial
CC       cells. Tyrosine kinases are probably involved in the entry
CC       process. Virus binding to PVR induces increased junctional
CC       permeability and rearrangement of junctional proteins. Modulation
CC       of endothelial tight junctions, as well as cytolytic infection of
CC       endothelial cells themselves, may result in loss of endothelial
CC       integrity which may help the virus to reach the CNS. After binding
CC       to its receptor, the capsid undergoes conformational changes.
CC       Capsid protein VP1 N-terminus (that contains an amphipathic alpha-
CC       helix) and capsid protein VP4 are externalized. Together, they
CC       shape a pore in the host membrane through which viral genome is
CC       translocated to host cell cytoplasm. After genome has been
CC       released, the channel shrinks.
CC   -!- FUNCTION: Capsid protein VP2: Forms an icosahedral capsid of
CC       pseudo T=3 symmetry with capsid proteins VP2 and VP3. The capsid
CC       is 300 Angstroms in diameter, composed of 60 copies of each capsid
CC       protein and enclosing the viral positive strand RNA genome.
CC   -!- FUNCTION: Capsid protein VP3: Forms an icosahedral capsid of
CC       pseudo T=3 symmetry with capsid proteins VP2 and VP3. The capsid
CC       is 300 Angstroms in diameter, composed of 60 copies of each capsid
CC       protein and enclosing the viral positive strand RNA genome.
CC   -!- FUNCTION: Capsid protein VP4: Lies on the inner surface of the
CC       capsid shell. After binding to the host receptor, the capsid
CC       undergoes conformational changes. Capsid protein VP4 is released,
CC       Capsid protein VP1 N-terminus is externalized, and together, they
CC       shape a pore in the host membrane through which the viral genome
CC       is translocated into the host cell cytoplasm. After genome has
CC       been released, the channel shrinks (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: Capsid protein VP0: Component of immature procapsids,
CC       which is cleaved into capsid proteins VP4 and VP2 after
CC       maturation. Allows the capsid to remain inactive before the
CC       maturation step (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: Protein 2A: Cysteine protease that cleaves viral
CC       polyprotein and specific host proteins. It is responsible for the
CC       cleavage between the P1 and P2 regions, first cleavage occurring
CC       in the polyprotein. Cleaves also the host translation initiation
CC       factor EIF4G1, in order to shut down the capped cellular mRNA
CC       translation. Inhibits the host nucleus-cytoplasm protein and RNA
CC       trafficking by cleaving host members of the nuclear pores
CC       including NUP98, NUP62 and NUP153.
CC   -!- FUNCTION: Protein 2B: Plays an essential role in the virus
CC       replication cycle by acting as a viroporin. Creates a pore in the
CC       host reticulum endoplasmic and as a consequence releases Ca2+ in
CC       the cytoplasm of infected cell. In turn, high levels of
CC       cyctoplasmic calcium may trigger membrane trafficking and
CC       transport of viral ER-associated proteins to viroplasms, sites of
CC       viral genome replication.
CC   -!- FUNCTION: Protein 2C: Induces and associates with structural
CC       rearrangements of intracellular membranes. Triggers host autophagy
CC       by interacting with host BECN1 and thereby promotes viral
CC       replication. Participates in viral replication and interacts with
CC       host DHX9. Displays RNA-binding, nucleotide binding and NTPase
CC       activities. May play a role in virion morphogenesis and viral RNA
CC       encapsidation by interacting with the capsid protein VP3.
CC   -!- FUNCTION: Protein 3AB: Localizes the viral replication complex to
CC       the surface of membranous vesicles. Together with protein 3CD
CC       binds the Cis-Active RNA Element (CRE) which is involved in RNA
CC       synthesis initiation. Acts as a cofactor to stimulate the activity
CC       of 3D polymerase, maybe through a nucleid acid chaperone activity.
CC   -!- FUNCTION: Protein 3A: Localizes the viral replication complex to
CC       the surface of membranous vesicles. It inhibits host cell
CC       endoplasmic reticulum-to-Golgi apparatus transport and causes the
CC       dissassembly of the Golgi complex, possibly through GBF1
CC       interaction. This would result in depletion of MHC, trail
CC       receptors and IFN receptors at the host cell surface.
CC   -!- FUNCTION: Viral protein genome-linked: acts as a primer for viral
CC       RNA replication and remains covalently bound to viral genomic RNA.
CC       VPg is uridylylated prior to priming replication into VPg-pUpU.
CC       The oriI viral genomic sequence may act as a template for this.
CC       The VPg-pUpU is then used as primer on the genomic RNA poly(A) by
CC       the RNA-dependent RNA polymerase to replicate the viral genome.
CC       VPg may be removed in the cytoplasm by an unknown enzyme termed
CC       "unlinkase". VPg is not cleaved off virion genomes because
CC       replicated genomic RNA are encapsidated at the site of
CC       replication.
CC   -!- FUNCTION: Protein 3CD: Is involved in the viral replication
CC       complex and viral polypeptide maturation. It exhibits protease
CC       activity with a specificity and catalytic efficiency that is
CC       different from protease 3C. Protein 3CD lacks polymerase activity.
CC       The 3C domain in the context of protein 3CD may have an RNA
CC       binding activity.
CC   -!- FUNCTION: Protease 3C: May cleave host PABP and contribute to host
CC       translation shutoff.
CC   -!- FUNCTION: RNA-directed RNA polymerase: Replicates the viral
CC       genomic RNA on the surface of intracellular membranes. May form
CC       linear arrays of subunits that propagate along a strong head-to-
CC       tail interaction called interface-I. Covalently attaches UMP to a
CC       tyrosine of VPg, which is used to prime RNA synthesis. The
CC       positive stranded RNA genome is first replicated at virus induced
CC       membranous vesicles, creating a dsRNA genomic replication form.
CC       This dsRNA is then used as template to synthesize positive
CC       stranded RNA genomes. ss(+)RNA genomes are either translated,
CC       replicated or encapsidated.
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1). {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- CATALYTIC ACTIVITY: Selective cleavage of Tyr-|-Gly bond in the
CC       picornavirus polyprotein.
CC   -!- CATALYTIC ACTIVITY: Selective cleavage of Gln-|-Gly bond in the
CC       poliovirus polyprotein. In other picornavirus reactions Glu may be
CC       substituted for Gln, and Ser or Thr for Gly.
CC   -!- CATALYTIC ACTIVITY: NTP + H(2)O = NDP + phosphate.
CC   -!- ENZYME REGULATION: RNA-directed RNA polymerase: replication or
CC       transcription is subject to high level of random mutations by the
CC       nucleotide analog ribavirin.
CC   -!- SUBUNIT: Capsid protein VP1: Interacts with capsid protein VP0,
CC       and capsid protein VP3 to form heterotrimeric protomers. Five
CC       protomers subsequently associate to form pentamers which serve as
CC       building blocks for the capsid. Interacts with human PVR.
CC       Interacts with capsid protein VP4 in the mature capsid. Capsid
CC       protein VP0: interacts with capsid protein VP1 and capsid protein
CC       VP3 to form heterotrimeric protomers. Five protomers subsequently
CC       associate to form pentamers which serve as building blocks for the
CC       capsid. Capsid protein VP2: Interacts with capsid protein VP1 and
CC       capsid protein VP3 in the mature capsid. Capsid protein VP3:
CC       interacts with capsid protein VP0 and capsid protein VP1 to form
CC       heterotrimeric protomers. Five protomers subsequently associate to
CC       form pentamers which serve as building blocks for the capsid.
CC       Interacts with capsid protein VP4 in the mature capsid. Capsid
CC       protein VP4: Interacts with capsid protein VP1 and capsid protein
CC       VP3. Protein 2C: interacts with cellular Vimentin/VIM and BECN1;
CC       these interactions play important roles in the viral replication
CC       (By similarity). Protein 2C: interacts with capsid protein VP3;
CC       this interaction may be important for virion morphogenesis.
CC       Protein 2C: interacts with host BECN1 and DHX9 and possibly
CC       presents an hexameric ring structure with 6-fold symmetry
CC       characteristic of AAA+ ATPases. Protein 2C: N-terminus interacts
CC       with human RTN3. This interaction is important for viral
CC       replication (By similarity). Protein 3AB: interacts with protein
CC       3CD. Protein 3A: homodimerizes and interacts with host GBF1. Viral
CC       protein genome-linked: interacts with RNA-directed RNA polymerase.
CC       Protein 3CD: interacts with protein 3AB and with RNA-directed RNA
CC       polymerase. RNA-directed RNA polymerase: interacts with Viral
CC       protein genome-linked and with protein 3CD. {ECO:0000250,
CC       ECO:0000269|PubMed:16138011, ECO:0000269|PubMed:17005635,
CC       ECO:0000269|PubMed:17182608, ECO:0000269|PubMed:17409142,
CC       ECO:0000269|PubMed:20865167, ECO:0000269|PubMed:21345960,
CC       ECO:0000269|PubMed:7929441}.
CC   -!- SUBCELLULAR LOCATION: Capsid protein VP0: Virion. Host cytoplasm
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Capsid protein VP4: Virion.
CC   -!- SUBCELLULAR LOCATION: Capsid protein VP2: Virion. Host cytoplasm
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Capsid protein VP3: Virion. Host cytoplasm
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Capsid protein VP1: Virion. Host cytoplasm
CC       {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Protein 2B: Host cytoplasmic vesicle
CC       membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Note=Probably localizes to the
CC       surface of intracellular membrane vesicles that are induced after
CC       virus infection as the site for viral RNA replication. These
CC       vesicles are derived from the endoplasmic reticulum.
CC   -!- SUBCELLULAR LOCATION: Protein 2C: Host cytoplasmic vesicle
CC       membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Note=Probably localizes to the
CC       surface of intracellular membrane vesicles that are induced after
CC       virus infection as the site for viral RNA replication. These
CC       vesicles are derived from the endoplasmic reticulum.
CC   -!- SUBCELLULAR LOCATION: Protein 3A: Host cytoplasmic vesicle
CC       membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Note=Probably localizes to the
CC       surface of intracellular membrane vesicles that are induced after
CC       virus infection as the site for viral RNA replication. These
CC       vesicles are derived from the endoplasmic reticulum.
CC   -!- SUBCELLULAR LOCATION: Protein 3AB: Host cytoplasmic vesicle
CC       membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Note=Probably localizes to the
CC       surface of intracellular membrane vesicles that are induced after
CC       virus infection as the site for viral RNA replication. These
CC       vesicles are derived from the endoplasmic reticulum.
CC   -!- SUBCELLULAR LOCATION: Viral protein genome-linked: Virion. Host
CC       cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Protease 3C: Host cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Protein 3CD: Host cytoplasmic vesicle
CC       membrane {ECO:0000305}; Peripheral membrane protein {ECO:0000305};
CC       Cytoplasmic side {ECO:0000305}. Note=Probably localizes to the
CC       surface of intracellular membrane vesicles that are induced after
CC       virus infection as the site for viral RNA replication. These
CC       vesicles are derived from the endoplasmic reticulum.
CC   -!- SUBCELLULAR LOCATION: RNA-directed RNA polymerase: Host
CC       cytoplasmic vesicle membrane {ECO:0000305}; Peripheral membrane
CC       protein {ECO:0000305}; Cytoplasmic side {ECO:0000305}.
CC       Note=Probably localizes to the surface of intracellular membrane
CC       vesicles that are induced after virus infection as the site for
CC       viral RNA replication. These vesicles are derived from the
CC       endoplasmic reticulum.
CC   -!- PTM: Capsid protein VP0: Myristoylation is required for the
CC       formation of pentamers during virus assembly. Further assembly of
CC       12 pentamers and a molecule of genomic RNA generates the provirion
CC       (By similarity). {ECO:0000250}.
CC   -!- PTM: Genome polyprotein: Specific enzymatic cleavages in vivo by
CC       the viral proteases yield processing intermediates and the mature
CC       proteins.
CC   -!- PTM: Capsid protein VP0: During virion maturation, immature
CC       virions are rendered infectious following cleavage of VP0 into VP4
CC       and VP2. This maturation seems to be an autocatalytic event
CC       triggered by the presence of RNA in the capsid and it is followed
CC       by a conformational change infectious virion.
CC   -!- PTM: Viral protein genome-linked: VPg is uridylylated by the
CC       polymerase into VPg-pUpU. This acts as a nucleotide-peptide primer
CC       for the genomic RNA replication.
CC   -!- SIMILARITY: Belongs to the picornaviruses polyprotein family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 peptidase C3 domains. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 RdRp catalytic domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00539}.
CC   -!- SIMILARITY: Contains 1 SF3 helicase domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00551}.
CC   -!- CAUTION: Protein 3A: Has been proposed to interact with host
CC       LIS1/NUF (PubMed:16138011), but this has not been confirmed by
CC       other studies (PubMed:21345960). {ECO:0000305|PubMed:16138011,
CC       ECO:0000305|PubMed:21345960}.
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure associated with cellular receptor;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1dgi";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure associated with cellular receptor;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1nn8";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure in complex with R80633, an inhibitor of viral
CC       replication;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1po1";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure in complex with R77975, an inhibitor of viral
CC       replication;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1po2";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       empty capsid structure;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1pov";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure complexed with R78206;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1vbd";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=2plv";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure of 135S cell entry intermediate;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1xyr";
CC   -!- WEB RESOURCE: Name=Virus Particle ExploreR db; Note=Icosahedral
CC       capsid structure;
CC       URL="http://viperdb.scripps.edu/info_page.php?VDB=1hxs";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; V01149; CAA24461.1; -; Genomic_RNA.
DR   EMBL; V01148; CAA24446.1; -; Genomic_RNA.
DR   PIR; A03898; GNNY2P.
DR   PIR; A93258; GNNY1P.
DR   RefSeq; NP_041277.1; NC_002058.3.
DR   PDB; 1AL2; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1AR6; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1AR7; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1AR8; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1AR9; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1ASJ; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1DGI; EM; 22.00 A; 1=599-881, 2=74-341, 3=342-576, 4=2-69.
DR   PDB; 1FPT; X-ray; 3.00 A; P=665-682.
DR   PDB; 1HXS; X-ray; 2.20 A; 1=580-881, 2=70-341, 3=342-578, 4=2-69.
DR   PDB; 1L1N; X-ray; 2.10 A; A/B=1566-1748.
DR   PDB; 1NG7; NMR; -; A/B=1457-1515.
DR   PDB; 1NN8; EM; 15.00 A; 1=580-881, 2=70-341, 3=342-576, 4=2-69.
DR   PDB; 1PO1; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1PO2; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1POV; X-ray; 2.80 A; 0=2-341, 1=580-881, 3=342-579.
DR   PDB; 1RA6; X-ray; 2.00 A; A=1749-2209.
DR   PDB; 1RA7; X-ray; 2.35 A; A=1749-2209.
DR   PDB; 1RAJ; X-ray; 2.50 A; A=1817-2209.
DR   PDB; 1RDR; X-ray; 2.40 A; A=1749-2209.
DR   PDB; 1TQL; X-ray; 2.30 A; A=1749-2209.
DR   PDB; 1VBD; X-ray; 2.90 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 1XYR; EM; 11.00 A; 1=650-881, 2=97-333, 3=391-572, 5=342-353, 6=355-390, 7=82-95, 8=621-631.
DR   PDB; 2BBL; NMR; -; A=1544-1565.
DR   PDB; 2BBP; NMR; -; A=1544-1565.
DR   PDB; 2IJD; X-ray; 3.40 A; 1/2=1566-2208.
DR   PDB; 2IJF; X-ray; 3.00 A; A=1749-2208.
DR   PDB; 2ILY; X-ray; 2.60 A; A=1749-2208.
DR   PDB; 2ILZ; X-ray; 2.50 A; A=1749-2208.
DR   PDB; 2IM0; X-ray; 2.25 A; A=1749-2208.
DR   PDB; 2IM1; X-ray; 2.50 A; A=1749-2208.
DR   PDB; 2IM2; X-ray; 2.35 A; A=1749-2208.
DR   PDB; 2IM3; X-ray; 2.60 A; A=1749-2208.
DR   PDB; 2PLV; X-ray; 2.88 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 3EPC; EM; 8.00 A; 1=599-881, 2=74-341, 3=342-576, 4=2-69.
DR   PDB; 3IYB; EM; -; 1=647-881, 4=97-341.
DR   PDB; 3IYC; EM; -; 1=647-881, 4=97-341.
DR   PDB; 3J3O; EM; 11.10 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 3J3P; EM; 9.10 A; 1=580-881, 2=70-341, 3=342-579.
DR   PDB; 3J48; EM; 5.50 A; 1=580-881, 2=70-341, 3=342-579.
DR   PDB; 3J69; EM; 4.80 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 3J6A; EM; 6.50 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 3J8F; EM; 3.70 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 3J9F; EM; 9.00 A; 1=580-881, 2=70-341, 3=342-579, 4=2-69.
DR   PDB; 3OL7; X-ray; 2.70 A; A/E/I/M=1749-2209.
DR   PDB; 4DCD; X-ray; 1.69 A; A=1566-1748.
DR   PDB; 4K4S; X-ray; 2.40 A; A/E=1749-2209.
DR   PDB; 4K4T; X-ray; 2.75 A; A/E=1749-2209.
DR   PDB; 4K4U; X-ray; 2.85 A; A/E=1749-2209.
DR   PDB; 4K4V; X-ray; 2.63 A; A/E=1749-2209.
DR   PDB; 4K4W; X-ray; 2.69 A; A/E=1749-2209.
DR   PDB; 4NLO; X-ray; 2.20 A; A=1749-2209.
DR   PDB; 4NLP; X-ray; 2.20 A; A=1749-2209.
DR   PDB; 4NLQ; X-ray; 2.30 A; A=1749-2209.
DR   PDB; 4NLR; X-ray; 2.00 A; A=1749-2209.
DR   PDB; 4NLS; X-ray; 2.00 A; A=1749-2209.
DR   PDB; 4NLT; X-ray; 2.50 A; A=1749-2209.
DR   PDB; 4NLU; X-ray; 2.10 A; A=1749-2209.
DR   PDB; 4NLV; X-ray; 2.30 A; A=1749-2209.
DR   PDB; 4NLW; X-ray; 2.10 A; A=1749-2209.
DR   PDB; 4NLX; X-ray; 2.60 A; A=1749-2209.
DR   PDB; 4NLY; X-ray; 2.30 A; A=1749-2209.
DR   PDB; 4R0E; X-ray; 3.00 A; A=1749-2209.
DR   PDBsum; 1AL2; -.
DR   PDBsum; 1AR6; -.
DR   PDBsum; 1AR7; -.
DR   PDBsum; 1AR8; -.
DR   PDBsum; 1AR9; -.
DR   PDBsum; 1ASJ; -.
DR   PDBsum; 1DGI; -.
DR   PDBsum; 1FPT; -.
DR   PDBsum; 1HXS; -.
DR   PDBsum; 1L1N; -.
DR   PDBsum; 1NG7; -.
DR   PDBsum; 1NN8; -.
DR   PDBsum; 1PO1; -.
DR   PDBsum; 1PO2; -.
DR   PDBsum; 1POV; -.
DR   PDBsum; 1RA6; -.
DR   PDBsum; 1RA7; -.
DR   PDBsum; 1RAJ; -.
DR   PDBsum; 1RDR; -.
DR   PDBsum; 1TQL; -.
DR   PDBsum; 1VBD; -.
DR   PDBsum; 1XYR; -.
DR   PDBsum; 2BBL; -.
DR   PDBsum; 2BBP; -.
DR   PDBsum; 2IJD; -.
DR   PDBsum; 2IJF; -.
DR   PDBsum; 2ILY; -.
DR   PDBsum; 2ILZ; -.
DR   PDBsum; 2IM0; -.
DR   PDBsum; 2IM1; -.
DR   PDBsum; 2IM2; -.
DR   PDBsum; 2IM3; -.
DR   PDBsum; 2PLV; -.
DR   PDBsum; 3EPC; -.
DR   PDBsum; 3IYB; -.
DR   PDBsum; 3IYC; -.
DR   PDBsum; 3J3O; -.
DR   PDBsum; 3J3P; -.
DR   PDBsum; 3J48; -.
DR   PDBsum; 3J69; -.
DR   PDBsum; 3J6A; -.
DR   PDBsum; 3J8F; -.
DR   PDBsum; 3J9F; -.
DR   PDBsum; 3OL7; -.
DR   PDBsum; 4DCD; -.
DR   PDBsum; 4K4S; -.
DR   PDBsum; 4K4T; -.
DR   PDBsum; 4K4U; -.
DR   PDBsum; 4K4V; -.
DR   PDBsum; 4K4W; -.
DR   PDBsum; 4NLO; -.
DR   PDBsum; 4NLP; -.
DR   PDBsum; 4NLQ; -.
DR   PDBsum; 4NLR; -.
DR   PDBsum; 4NLS; -.
DR   PDBsum; 4NLT; -.
DR   PDBsum; 4NLU; -.
DR   PDBsum; 4NLV; -.
DR   PDBsum; 4NLW; -.
DR   PDBsum; 4NLX; -.
DR   PDBsum; 4NLY; -.
DR   PDBsum; 4R0E; -.
DR   ProteinModelPortal; P03300; -.
DR   SMR; P03300; 2-579, 599-1030, 1457-1515, 1566-2209.
DR   BindingDB; P03300; -.
DR   ChEMBL; CHEMBL5127; -.
DR   MEROPS; N08.001; -.
DR   GeneID; 919920; -.
DR   KEGG; vg:919920; -.
DR   EvolutionaryTrace; P03300; -.
DR   PMAP-CutDB; P03299; -.
DR   Proteomes; UP000000356; Genome.
DR   GO; GO:0044162; C:host cell cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0044385; C:integral to membrane of host cell; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0039618; C:T=pseudo3 icosahedral viral capsid; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004197; F:cysteine-type endopeptidase activity; IEA:InterPro.
DR   GO; GO:0005216; F:ion channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003724; F:RNA helicase activity; IEA:InterPro.
DR   GO; GO:0003968; F:RNA-directed RNA polymerase activity; IDA:CACAO.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0075509; P:endocytosis involved in viral entry into host cell; IEA:UniProtKB-KW.
DR   GO; GO:0039520; P:induction by virus of host autophagy; IDA:UniProtKB.
DR   GO; GO:0039707; P:pore formation by virus in membrane of host cell; IEA:UniProtKB-KW.
DR   GO; GO:0044694; P:pore-mediated entry of viral genome into host cell; IEA:UniProtKB-KW.
DR   GO; GO:0051259; P:protein oligomerization; IEA:UniProtKB-KW.
DR   GO; GO:0018144; P:RNA-protein covalent cross-linking; IEA:UniProtKB-KW.
DR   GO; GO:0039522; P:suppression by virus of host mRNA export from nucleus; IDA:UniProtKB.
DR   GO; GO:0039544; P:suppression by virus of host RIG-I activity by RIG-I proteolysis; IDA:UniProtKB.
DR   GO; GO:0039611; P:suppression by virus of host translation initiation factor activity; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0001172; P:transcription, RNA-templated; IDA:GOC.
DR   GO; GO:0039694; P:viral RNA genome replication; IEA:InterPro.
DR   GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.120.20; -; 3.
DR   Gene3D; 4.10.80.10; -; 2.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR000605; Helicase_SF3_ssDNA/RNA_vir.
DR   InterPro; IPR014759; Helicase_SF3_ssRNA_vir.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR014838; P3A.
DR   InterPro; IPR000081; Peptidase_C3.
DR   InterPro; IPR000199; Peptidase_C3A/C3B_picornavir.
DR   InterPro; IPR003138; Pico_P1A.
DR   InterPro; IPR002527; Pico_P2B.
DR   InterPro; IPR001676; Picornavirus_capsid.
DR   InterPro; IPR001205; RNA-dir_pol_C.
DR   InterPro; IPR007094; RNA-dir_pol_PSvirus.
DR   InterPro; IPR009003; Trypsin-like_Pept_dom.
DR   InterPro; IPR029053; Viral_coat.
DR   Pfam; PF08727; P3A; 1.
DR   Pfam; PF00548; Peptidase_C3; 1.
DR   Pfam; PF02226; Pico_P1A; 1.
DR   Pfam; PF00947; Pico_P2A; 1.
DR   Pfam; PF01552; Pico_P2B; 1.
DR   Pfam; PF00680; RdRP_1; 1.
DR   Pfam; PF00073; Rhv; 3.
DR   Pfam; PF00910; RNA_helicase; 1.
DR   ProDom; PD001306; Peptidase_C3; 1.
DR   ProDom; PD649346; Pico_P2B; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF50494; SSF50494; 2.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF89043; SSF89043; 1.
DR   PROSITE; PS50507; RDRP_SSRNA_POS; 1.
DR   PROSITE; PS51218; SF3_HELICASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activation of host autophagy by virus; ATP-binding;
KW   Capsid protein; Complete proteome; Covalent protein-RNA linkage;
KW   Direct protein sequencing;
KW   Eukaryotic host gene expression shutoff by virus;
KW   Eukaryotic host translation shutoff by virus; Helicase;
KW   Host cytoplasm; Host cytoplasmic vesicle;
KW   Host gene expression shutoff by virus; Host membrane;
KW   Host mRNA suppression by virus; Host-virus interaction; Hydrolase;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host mRNA nuclear export by virus;
KW   Inhibition of host RIG-I by virus;
KW   Inhibition of host RLR pathway by virus; Ion channel; Ion transport;
KW   Lipoprotein; Membrane; Myristate; Nucleotide-binding;
KW   Nucleotidyltransferase; Phosphoprotein;
KW   Pore-mediated penetration of viral genome into host cell; Protease;
KW   Reference proteome; Repeat; RNA-binding; RNA-directed RNA polymerase;
KW   T=pseudo3 icosahedral capsid protein; Thiol protease; Transferase;
KW   Transport; Viral attachment to host cell; Viral immunoevasion;
KW   Viral ion channel; Viral penetration into host cytoplasm;
KW   Viral RNA replication; Virion; Virus endocytosis by host;
KW   Virus entry into host cell.
FT   INIT_MET      1      1       Removed; by host. {ECO:0000250}.
FT   CHAIN         2   2209       Genome polyprotein.
FT                                /FTId=PRO_0000424686.
FT   CHAIN         2    881       P1.
FT                                /FTId=PRO_0000424687.
FT   CHAIN         2    341       Capsid protein VP0. {ECO:0000255}.
FT                                /FTId=PRO_0000424688.
FT   CHAIN         2     69       Capsid protein VP4. {ECO:0000255}.
FT                                /FTId=PRO_0000040080.
FT   CHAIN        70    341       Capsid protein VP2. {ECO:0000255}.
FT                                /FTId=PRO_0000040081.
FT   CHAIN       342    579       Capsid protein VP3. {ECO:0000255}.
FT                                /FTId=PRO_0000040082.
FT   CHAIN       580    881       Capsid protein VP1. {ECO:0000255}.
FT                                /FTId=PRO_0000040083.
FT   CHAIN       882   1456       P2.
FT                                /FTId=PRO_0000424689.
FT   CHAIN       882   1030       Protease 2A. {ECO:0000255}.
FT                                /FTId=PRO_0000040084.
FT   CHAIN      1031   1127       Protein 2B. {ECO:0000255}.
FT                                /FTId=PRO_0000040085.
FT   CHAIN      1128   1456       Protein 2C. {ECO:0000255}.
FT                                /FTId=PRO_0000040086.
FT   CHAIN      1457   2209       P3.
FT                                /FTId=PRO_0000424690.
FT   CHAIN      1457   1565       Protein 3AB. {ECO:0000255}.
FT                                /FTId=PRO_0000424691.
FT   CHAIN      1457   1543       Protein 3A. {ECO:0000255}.
FT                                /FTId=PRO_0000424692.
FT   CHAIN      1544   1565       Viral protein genome-linked.
FT                                {ECO:0000255}.
FT                                /FTId=PRO_0000040088.
FT   CHAIN      1566   2209       Protein 3CD. {ECO:0000255}.
FT                                /FTId=PRO_0000424693.
FT   CHAIN      1566   1747       Protease 3C. {ECO:0000255}.
FT                                /FTId=PRO_0000040089.
FT   CHAIN      1748   2209       RNA-directed RNA polymerase.
FT                                /FTId=PRO_0000040090.
FT   TOPO_DOM      2   1520       Cytoplasmic. {ECO:0000255}.
FT   INTRAMEM   1521   1536       {ECO:0000255}.
FT   TOPO_DOM   1537   2209       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      882   1031       Peptidase C3 1.
FT   DOMAIN     1232   1388       SF3 helicase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00551}.
FT   DOMAIN     1566   1731       Peptidase C3 2.
FT   DOMAIN     1975   2090       RdRp catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00539}.
FT   NP_BIND    1256   1263       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00551}.
FT   REGION      580    600       Amphipatic alpha-helix. {ECO:0000255}.
FT   REGION     1457   1479       Disordered.
FT   ACT_SITE    901    901       For Protease 2A activity. {ECO:0000250}.
FT   ACT_SITE    919    919       For Protease 2A activity. {ECO:0000250}.
FT   ACT_SITE    990    990       For Protease 2A activity. {ECO:0000250}.
FT   ACT_SITE   1605   1605       For Protease 3C activity. {ECO:0000255}.
FT   ACT_SITE   1636   1636       For Protease 3C activity. {ECO:0000255}.
FT   ACT_SITE   1712   1712       For Protease 3C activity. {ECO:0000255}.
FT   ACT_SITE   2076   2076       For RdRp activity.
FT                                {ECO:0000269|PubMed:2196557}.
FT   SITE         25     25       Involved in the interaction with human
FT                                RTN3. {ECO:0000250}.
FT   SITE         69     70       Cleavage; by autolysis. {ECO:0000255}.
FT   SITE        341    342       Cleavage; by Protease 3C. {ECO:0000255}.
FT   SITE        881    882       Cleavage; by Protease 2A. {ECO:0000255}.
FT   SITE       1030   1031       Cleavage; by Protease 3C. {ECO:0000255}.
FT   SITE       1127   1128       Cleavage; by Protease 3C. {ECO:0000255}.
FT   SITE       1456   1457       Cleavage; by Protease 3C. {ECO:0000255}.
FT   SITE       1543   1544       Cleavage; by Protease 3C. {ECO:0000255}.
FT   SITE       1565   1566       Cleavage; by Protease 3C. {ECO:0000255}.
FT   SITE       1748   1749       Cleavage; by Protease 3C. {ECO:0000255}.
FT   MOD_RES    1546   1546       O-(5'-phospho-RNA)-tyrosine.
FT   MOD_RES    1546   1546       O-UMP-tyrosine; transient.
FT                                {ECO:0000269|PubMed:12502805,
FT                                ECO:0000269|PubMed:16840321}.
FT   LIPID         2      2       N-myristoyl glycine; by host.
FT                                {ECO:0000269|PubMed:10618374,
FT                                ECO:0000269|PubMed:1850017,
FT                                ECO:0000269|PubMed:1851815}.
FT   MUTAGEN       2      2       G->A: 100% loss of myristoylation.
FT                                Impaired viral assembly.
FT                                {ECO:0000269|PubMed:1851815}.
FT   MUTAGEN       3      3       A->D: 50% loss of myristoylation. Severe
FT                                reduction in specific infectivity.
FT                                {ECO:0000269|PubMed:1850017}.
FT   MUTAGEN       3      3       A->G,L,V: No effect on myristoylation and
FT                                virus growth.
FT                                {ECO:0000269|PubMed:1850017}.
FT   MUTAGEN       3      3       A->H: No effect on myristoylation. Severe
FT                                reduction in specific infectivity.
FT                                {ECO:0000269|PubMed:1850017}.
FT   CONFLICT    242    264       RFCPVDYLLGNGTLLGNAFVFPH -> SSARWITSLEMARC
FT                                WGMPLCSA (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    287    287       I -> L (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    309    309       A -> V (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    420    422       DDP -> AAS (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    464    464       F -> S (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    515    515       T -> S (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    855    856       AV -> QL (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    972    972       A -> V (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT    985    985       A -> E (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1140   1141       NA -> QR (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1619   1619       V -> A (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1626   1627       AL -> VF (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1635   1635       L -> F (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1682   1682       G -> R (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1722   1730       VIGMHVGGN -> SSGCMLVD (in Ref. 2;
FT                                CAA24446). {ECO:0000305}.
FT   CONFLICT   1743   1743       Y -> L (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1752   1752       Q -> P (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1759   1760       EV -> DA (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   CONFLICT   1840   1840       T -> I (in Ref. 2; CAA24446).
FT                                {ECO:0000305}.
FT   STRAND        3      7       {ECO:0000244|PDB:1HXS}.
FT   STRAND       17     23       {ECO:0000244|PDB:1HXS}.
FT   STRAND       26     29       {ECO:0000244|PDB:1HXS}.
FT   STRAND       33     35       {ECO:0000244|PDB:1AL2}.
FT   HELIX        36     38       {ECO:0000244|PDB:1HXS}.
FT   HELIX        51     54       {ECO:0000244|PDB:1HXS}.
FT   STRAND       57     59       {ECO:0000244|PDB:1HXS}.
FT   HELIX        66     69       {ECO:0000244|PDB:1POV}.
FT   HELIX        74     76       {ECO:0000244|PDB:1POV}.
FT   STRAND       83     87       {ECO:0000244|PDB:1HXS}.
FT   STRAND       90     96       {ECO:0000244|PDB:1HXS}.
FT   STRAND      100    102       {ECO:0000244|PDB:1POV}.
FT   HELIX       103    105       {ECO:0000244|PDB:1HXS}.
FT   HELIX       113    115       {ECO:0000244|PDB:1HXS}.
FT   HELIX       126    128       {ECO:0000244|PDB:1HXS}.
FT   STRAND      138    141       {ECO:0000244|PDB:1HXS}.
FT   STRAND      147    151       {ECO:0000244|PDB:1HXS}.
FT   HELIX       153    155       {ECO:0000244|PDB:1HXS}.
FT   HELIX       159    167       {ECO:0000244|PDB:1HXS}.
FT   STRAND      168    180       {ECO:0000244|PDB:1HXS}.
FT   STRAND      187    197       {ECO:0000244|PDB:1HXS}.
FT   STRAND      206    210       {ECO:0000244|PDB:1HXS}.
FT   HELIX       214    217       {ECO:0000244|PDB:1HXS}.
FT   HELIX       220    222       {ECO:0000244|PDB:1HXS}.
FT   STRAND      227    229       {ECO:0000244|PDB:1HXS}.
FT   STRAND      236    238       {ECO:0000244|PDB:1HXS}.
FT   HELIX       247    249       {ECO:0000244|PDB:1HXS}.
FT   TURN        250    253       {ECO:0000244|PDB:1HXS}.
FT   HELIX       256    261       {ECO:0000244|PDB:1HXS}.
FT   STRAND      262    268       {ECO:0000244|PDB:1HXS}.
FT   TURN        269    271       {ECO:0000244|PDB:1HXS}.
FT   STRAND      273    279       {ECO:0000244|PDB:1HXS}.
FT   STRAND      284    288       {ECO:0000244|PDB:1HXS}.
FT   TURN        290    292       {ECO:0000244|PDB:1HXS}.
FT   STRAND      296    308       {ECO:0000244|PDB:1HXS}.
FT   STRAND      311    313       {ECO:0000244|PDB:1AR7}.
FT   STRAND      315    332       {ECO:0000244|PDB:1HXS}.
FT   TURN        349    352       {ECO:0000244|PDB:1HXS}.
FT   STRAND      364    366       {ECO:0000244|PDB:1HXS}.
FT   STRAND      380    383       {ECO:0000244|PDB:1HXS}.
FT   HELIX       384    388       {ECO:0000244|PDB:1HXS}.
FT   TURN        400    404       {ECO:0000244|PDB:1HXS}.
FT   HELIX       406    409       {ECO:0000244|PDB:1HXS}.
FT   STRAND      411    414       {ECO:0000244|PDB:1HXS}.
FT   STRAND      423    428       {ECO:0000244|PDB:1HXS}.
FT   TURN        430    432       {ECO:0000244|PDB:1HXS}.
FT   TURN        434    438       {ECO:0000244|PDB:1HXS}.
FT   HELIX       440    445       {ECO:0000244|PDB:1HXS}.
FT   STRAND      448    453       {ECO:0000244|PDB:1HXS}.
FT   STRAND      455    461       {ECO:0000244|PDB:1HXS}.
FT   STRAND      470    476       {ECO:0000244|PDB:1HXS}.
FT   STRAND      478    480       {ECO:0000244|PDB:1HXS}.
FT   HELIX       486    489       {ECO:0000244|PDB:1HXS}.
FT   STRAND      492    498       {ECO:0000244|PDB:1HXS}.
FT   STRAND      500    502       {ECO:0000244|PDB:1HXS}.
FT   STRAND      504    509       {ECO:0000244|PDB:1HXS}.
FT   STRAND      514    521       {ECO:0000244|PDB:1HXS}.
FT   HELIX       524    526       {ECO:0000244|PDB:1POV}.
FT   STRAND      530    537       {ECO:0000244|PDB:1HXS}.
FT   STRAND      547    557       {ECO:0000244|PDB:1HXS}.
FT   STRAND      562    566       {ECO:0000244|PDB:1HXS}.
FT   STRAND      570    572       {ECO:0000244|PDB:1POV}.
FT   STRAND      586    589       {ECO:0000244|PDB:1HXS}.
FT   STRAND      594    596       {ECO:0000244|PDB:2PLV}.
FT   HELIX       626    628       {ECO:0000244|PDB:1HXS}.
FT   HELIX       636    638       {ECO:0000244|PDB:1HXS}.
FT   HELIX       652    654       {ECO:0000244|PDB:1HXS}.
FT   HELIX       656    660       {ECO:0000244|PDB:1HXS}.
FT   STRAND      664    673       {ECO:0000244|PDB:1HXS}.
FT   STRAND      685    688       {ECO:0000244|PDB:1HXS}.
FT   STRAND      693    695       {ECO:0000244|PDB:1HXS}.
FT   HELIX       696    701       {ECO:0000244|PDB:1HXS}.
FT   STRAND      704    721       {ECO:0000244|PDB:1HXS}.
FT   STRAND      723    725       {ECO:0000244|PDB:1AR7}.
FT   STRAND      733    739       {ECO:0000244|PDB:1HXS}.
FT   HELIX       752    755       {ECO:0000244|PDB:1HXS}.
FT   STRAND      757    759       {ECO:0000244|PDB:1HXS}.
FT   STRAND      761    765       {ECO:0000244|PDB:1HXS}.
FT   STRAND      771    775       {ECO:0000244|PDB:1HXS}.
FT   STRAND      780    786       {ECO:0000244|PDB:1HXS}.
FT   STRAND      790    793       {ECO:0000244|PDB:1POV}.
FT   STRAND      796    799       {ECO:0000244|PDB:1POV}.
FT   TURN        801    804       {ECO:0000244|PDB:1HXS}.
FT   HELIX       812    814       {ECO:0000244|PDB:1HXS}.
FT   STRAND      818    823       {ECO:0000244|PDB:1HXS}.
FT   STRAND      832    850       {ECO:0000244|PDB:1HXS}.
FT   STRAND      860    863       {ECO:0000244|PDB:1HXS}.
FT   HELIX      1478   1484       {ECO:0000244|PDB:1NG7}.
FT   HELIX      1487   1496       {ECO:0000244|PDB:1NG7}.
FT   STRAND     1546   1550       {ECO:0000244|PDB:2BBL}.
FT   STRAND     1556   1558       {ECO:0000244|PDB:2BBL}.
FT   HELIX      1560   1564       {ECO:0000244|PDB:2BBL}.
FT   HELIX      1567   1579       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1580   1585       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1588   1597       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1599   1603       {ECO:0000244|PDB:4DCD}.
FT   HELIX      1604   1606       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1610   1614       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1617   1628       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1634   1645       {ECO:0000244|PDB:4DCD}.
FT   HELIX      1652   1654       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1662   1669       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1671   1674       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1677   1692       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1695   1705       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1715   1718       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1721   1729       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1734   1738       {ECO:0000244|PDB:4DCD}.
FT   HELIX      1741   1744       {ECO:0000244|PDB:4DCD}.
FT   STRAND     1750   1756       {ECO:0000244|PDB:1RA6}.
FT   TURN       1757   1761       {ECO:0000244|PDB:1RA6}.
FT   TURN       1763   1766       {ECO:0000244|PDB:1RDR}.
FT   HELIX      1770   1772       {ECO:0000244|PDB:1RDR}.
FT   TURN       1777   1781       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1786   1788       {ECO:0000244|PDB:4K4S}.
FT   STRAND     1792   1794       {ECO:0000244|PDB:4K4S}.
FT   HELIX      1802   1807       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1820   1834       {ECO:0000244|PDB:1RA6}.
FT   TURN       1835   1837       {ECO:0000244|PDB:1RA7}.
FT   HELIX      1845   1850       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1860   1862       {ECO:0000244|PDB:4NLR}.
FT   TURN       1866   1872       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1875   1878       {ECO:0000244|PDB:1RA6}.
FT   TURN       1881   1884       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1887   1895       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1902   1906       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1910   1912       {ECO:0000244|PDB:4K4S}.
FT   HELIX      1913   1917       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1923   1926       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1929   1948       {ECO:0000244|PDB:1RA6}.
FT   TURN       1952   1955       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1962   1965       {ECO:0000244|PDB:1RA6}.
FT   TURN       1966   1968       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1969   1972       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1975   1978       {ECO:0000244|PDB:1RA6}.
FT   STRAND     1981   1984       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1985   1988       {ECO:0000244|PDB:1RA6}.
FT   HELIX      1991   2003       {ECO:0000244|PDB:1RA6}.
FT   TURN       2004   2006       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2007   2010       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2011   2017       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2018   2023       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2026   2032       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2036   2038       {ECO:0000244|PDB:4NLV}.
FT   HELIX      2041   2060       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2061   2063       {ECO:0000244|PDB:4K4V}.
FT   HELIX      2066   2068       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2070   2074       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2077   2084       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2088   2097       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2102   2104       {ECO:0000244|PDB:1RA6}.
FT   TURN       2105   2107       {ECO:0000244|PDB:1RA6}.
FT   TURN       2116   2118       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2124   2128       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2130   2132       {ECO:0000244|PDB:1TQL}.
FT   STRAND     2135   2139       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2142   2149       {ECO:0000244|PDB:1RA6}.
FT   STRAND     2151   2153       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2155   2157       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2158   2169       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2170   2172       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2174   2184       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2188   2191       {ECO:0000244|PDB:1RA6}.
FT   HELIX      2198   2208       {ECO:0000244|PDB:1RA6}.
SQ   SEQUENCE   2209 AA;  246540 MW;  DF1754F87F2E97D6 CRC64;
     MGAQVSSQKV GAHENSNRAY GGSTINYTTI NYYRDSASNA ASKQDFSQDP SKFTEPIKDV
     LIKTAPMLNS PNIEACGYSD RVLQLTLGNS TITTQEAANS VVAYGRWPEY LRDSEANPVD
     QPTEPDVAAC RFYTLDTVSW TKESRGWWWK LPDALRDMGL FGQNMYYHYL GRSGYTVHVQ
     CNASKFHQGA LGVFAVPEMC LAGDSNTTTM HTSYQNANPG EKGGTFTGTF TPDNNQTSPA
     RRFCPVDYLL GNGTLLGNAF VFPHQIINLR TNNCATLVLP YVNSLSIDSM VKHNNWGIAI
     LPLAPLNFAS ESSPEIPITL TIAPMCCEFN GLRNITLPRL QGLPVMNTPG SNQYLTADNF
     QSPCALPEFD VTPPIDIPGE VKNMMELAEI DTMIPFDLSA TKKNTMEMYR VRLSDKPHTD
     DPILCLSLSP ASDPRLSHTM LGEILNYYTH WAGSLKFTFL FCGFMMATGK LLVSYAPPGA
     DPPKKRKEAM LGTHVIWDIG LQSSCTMVVP WISNTTYRQT IDDSFTEGGY ISVFYQTRIV
     VPLSTPREMD ILGFVSACND FSVRLLRDTT HIEQKALAQG LGQMLESMID NTVRETVGAA
     TSRDALPNTE ASGPTHSKEI PALTAVETGA TNPLVPSDTV QTRHVVQHRS RSESSIESFF
     ARGACVTIMT VDNPASTTNK DKLFAVWKIT YKDTVQLRRK LEFFTYSRFD MELTFVVTAN
     FTETNNGHAL NQVYQIMYVP PGAPVPEKWD DYTWQTSSNP SIFYTYGTAP ARISVPYVGI
     SNAYSHFYDG FSKVPLKDQS AALGDSLYGA ASLNDFGILA VRVVNDHNPT KVTSKIRVYL
     KPKHIRVWCP RPPRAVAYYG PGVDYKDGTL TPLSTKDLTT YGFGHQNKAV YTAGYKICNY
     HLATQDDLQN AVNVMWSRDL LVTESRAQGT DSIARCNCNA GVYYCESRRK YYPVSFVGPT
     FQYMEANNYY PARYQSHMLI GHGFASPGDC GGILRCHHGV IGIITAGGEG LVAFSDIRDL
     YAYEEEAMEQ GITNYIESLG AAFGSGFTQQ ISDKITELTN MVTSTITEKL LKNLIKIISS
     LVIITRNYED TTTVLATLAL LGCDASPWQW LRKKACDVLE IPYVIKQGDS WLKKFTEACN
     AAKGLEWVSN KISKFIDWLK EKIIPQARDK LEFVTKLRQL EMLENQISTI HQSCPSQEHQ
     EILFNNVRWL SIQSKRFAPL YAVEAKRIQK LEHTINNYIQ FKSKHRIEPV CLLVHGSPGT
     GKSVATNLIA RAIAERENTS TYSLPPDPSH FDGYKQQGVV IMDDLNQNPD GADMKLFCQM
     VSTVEFIPPM ASLEEKGILF TSNYVLASTN SSRISPPTVA HSDALARRFA FDMDIQVMNE
     YSRDGKLNMA MATEMCKNCH QPANFKRCCP LVCGKAIQLM DKSSRVRYSI DQITTMIINE
     RNRRSNIGNC MEALFQGPLQ YKDLKIDIKT SPPPECINDL LQAVDSQEVR DYCEKKGWIV
     NITSQVQTER NINRAMTILQ AVTTFAAVAG VVYVMYKLFA GHQGAYTGLP NKKPNVPTIR
     TAKVQGPGFD YAVAMAKRNI VTATTSKGEF TMLGVHDNVA ILPTHASPGE SIVIDGKEVE
     ILDAKALEDQ AGTNLEITII TLKRNEKFRD IRPHIPTQIT ETNDGVLIVN TSKYPNMYVP
     VGAVTEQGYL NLGGRQTART LMYNFPTRAG QCGGVITCTG KVIGMHVGGN GSHGFAAALK
     RSYFTQSQGE IQWMRPSKEV GYPIINAPSK TKLEPSAFHY VFEGVKEPAV LTKNDPRLKT
     DFEEAIFSKY VGNKITEVDE YMKEAVDHYA GQLMSLDINT EQMCLEDAMY GTDGLEALDL
     STSAGYPYVA MGKKKRDILN KQTRDTKEMQ KLLDTYGINL PLVTYVKDEL RSKTKVEQGK
     SRLIEASSLN DSVAMRMAFG NLYAAFHKNP GVITGSAVGC DPDLFWSKIP VLMEEKLFAF
     DYTGYDASLS PAWFEALKMV LEKIGFGDRV DYIDYLNHSH HLYKNKTYCV KGGMPSGCSG
     TSIFNSMINN LIIRTLLLKT YKGIDLDHLK MIAYGDDVIA SYPHEVDASL LAQSGKDYGL
     TMTPADKSAT FETVTWENVT FLKRFFRADE KYPFLIHPVM PMKEIHESIR WTKDPRNTQD
     HVRSLCLLAW HNGEEEYNKF LAKIRSVPIG RALLLPEYST LYRRWLDSF
//
